Manuel Gallén

2.2k total citations · 1 hit paper
33 papers, 1.5k citations indexed

About

Manuel Gallén is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Manuel Gallén has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Manuel Gallén's work include Colorectal Cancer Treatments and Studies (11 papers), Colorectal and Anal Carcinomas (8 papers) and Colorectal Cancer Surgical Treatments (7 papers). Manuel Gallén is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Colorectal and Anal Carcinomas (8 papers) and Colorectal Cancer Surgical Treatments (7 papers). Manuel Gallén collaborates with scholars based in Spain, United Kingdom and United States. Manuel Gallén's co-authors include Núria Malats, Miquel Porta, Joaquim Bellmunt, S. Coll, Esteve Fernández, Ricard Solà, C Alía, Antonio Sitges‐Serra, María Oliver-Ferrándiz and Montserrat Andreu and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Manuel Gallén

32 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

2012 367 citations Clara Montagut, Alba Dalmases et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuel Gallén Spain	17	1.0k	502	380	235	234	33	1.5k
Jeffrey P. Meyers United States	17	863 0.8×	528 1.1×	408 1.1×	207 0.9×	203 0.9×	40	1.4k
Marloes A.G. Elferink Netherlands	23	1.3k 1.3×	665 1.3×	419 1.1×	214 0.9×	163 0.7×	66	1.7k
Ludger Staib Germany	24	1.2k 1.2×	581 1.2×	430 1.1×	129 0.5×	190 0.8×	73	1.8k
Anja H. Loos Germany	10	1.6k 1.5×	331 0.7×	605 1.6×	393 1.7×	203 0.9×	16	2.0k
R. Adam France	13	947 0.9×	625 1.2×	454 1.2×	806 3.4×	215 0.9×	27	1.7k
Beodeul Kang South Korea	21	756 0.7×	322 0.6×	373 1.0×	344 1.5×	143 0.6×	99	1.4k
Stefano Cordio Italy	17	1.8k 1.8×	888 1.8×	705 1.9×	306 1.3×	242 1.0×	74	2.1k
Keiichiro Ishibashi Japan	19	809 0.8×	588 1.2×	522 1.4×	105 0.4×	138 0.6×	194	1.5k
Faysal Dane Türkiye	19	757 0.7×	303 0.6×	484 1.3×	76 0.3×	172 0.7×	131	1.3k
Thierry Delaunoit Belgium	16	817 0.8×	465 0.9×	366 1.0×	368 1.6×	73 0.3×	43	1.3k

Countries citing papers authored by Manuel Gallén

Since Specialization

Citations

This map shows the geographic impact of Manuel Gallén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Gallén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Gallén more than expected).

Fields of papers citing papers by Manuel Gallén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Gallén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Gallén. The network helps show where Manuel Gallén may publish in the future.

Co-authorship network of co-authors of Manuel Gallén

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Gallén. A scholar is included among the top collaborators of Manuel Gallén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Gallén. Manuel Gallén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Redlich, Allison D., Michael P. Donnelly, Manuel Gallén, et al.. (2025). Urgent issues and prospects in guilty plea research and practice. Legal and Criminological Psychology. 30(2). 193–211.

Sánchez‐Velázquez, Patricia, Miguél Pera, Marta Jiménez‐Toscano, et al.. (2018). Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer. Clinical & Translational Oncology. 20(10). 1321–1328. 22 indexed citations

Abad, Albert, José María Viéitez, Vicente Alonso, et al.. (2016). Effect of pharmacogenetic-based selection of first-line chemotherapy on response rate and R0 surgery in metastatic CRC patients.. Journal of Clinical Oncology. 34(15_suppl). 3530–3530. 2 indexed citations

Sastre, Javier, Marta Vidaurreta, Fernando Rivera, et al.. (2013). Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab. Clinical Colorectal Cancer. 12(4). 280–286. 30 indexed citations

Macià, Francesc, José Pumarega, Manuel Gallén, & Miquel Porta. (2013). Time from (clinical or certainty) diagnosis to treatment onset in cancer patients: the choice of diagnostic date strongly influences differences in therapeutic delay by tumor site and stage. Journal of Clinical Epidemiology. 66(8). 928–939. 19 indexed citations

Agüero, Fernando, Cristiane Murta‐Nascimento, Manuel Gallén, et al.. (2012). Colorectal cancer survival: Results from a hospital-based cancer registry. Revista Española de Enfermedades Digestivas. 104(11). 572–577. 21 indexed citations

Morales‐Barrera, Rafael, Joaquim Bellmunt, Cristina Suárez, et al.. (2012). Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function. European Journal of Cancer. 48(12). 1816–1821. 38 indexed citations

Montagut, Clara, Alba Dalmases, Beatríz Bellosillo, et al.. (2012). Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer. Nature Medicine. 18(2). 221–223. 367 indexed citations breakdown →

Becerra, Carlos, Ramón Salazar, Rocio García‐Carbonero, et al.. (2011). Phase II trial of figitumumab in patients with refractory, metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 29(15_suppl). 3525–3525. 6 indexed citations

10.

Montagut, Clara, Mar Iglesias, Beatríz Bellosillo, et al.. (2010). Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients. British Journal of Cancer. 102(7). 1137–1144. 21 indexed citations

11.

Carles, Joan, Cristina Suárez, Carlos Mesía, et al.. (2006). Feasibilty study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function. Clinical & Translational Oncology. 8(10). 755–757. 16 indexed citations

12.

Fernández, Esteve, et al.. (2002). Symptom-to-Diagnosis Interval and Survival in Cancers of the Digestive Tract. Digestive Diseases and Sciences. 47(11). 2434–2440. 43 indexed citations

13.

Abad, Albert, Enrique Aranda, Matilde Navarro, et al.. (2000). Two consecutive studies using oral UFT-based chemotherapy regimens in elderly patients with advanced colorectal cancer. 2(3). 154–158. 6 indexed citations

14.

Porta, Miquel, Núria Malats, Emily Morell, et al.. (1998). Decreased survival of patients with lung cancer admitted to a teaching hospital through the emergency department in Barcelona, Spain.. Journal of Epidemiology & Community Health. 52(2). 137–138. 7 indexed citations

15.

Porta, Miquel, et al.. (1998). Emergency admission for cancer: a matter of survival?. British Journal of Cancer. 77(3). 477–484. 52 indexed citations

16.

Gallén, Manuel, et al.. (1997). Anal carcinoma: a 14 year experience.. PubMed. 89(1). 23–8. 1 indexed citations

17.

Porta, Miquel, et al.. (1996). Predictors of the interval between onset of symptoms and first medical visit in patients with digestive tract cancer. International Journal of Oncology. 8(5). 941–9. 17 indexed citations

18.

Maguire, Andrew, Miquel Porta, Núria Malats, et al.. (1994). Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. European Journal of Cancer. 30(6). 785–792. 51 indexed citations

19.

Morales, Serafín, et al.. (1993). Alternating Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Phase II Study. Oncology. 50(4). 235–237. 4 indexed citations

20.

Andreu, Montserrat, Ricard Solà, Antonio Sitges‐Serra, et al.. (1993). Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology. 104(4). 1133–1138. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact